Sunday, May 27, 2018
Company News: Page (1) of 1 - 01/18/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Support Healthy Cholesterol Levels with HCP’s New LipiCept™ with Pantesin® Pantethine
(January 18, 2018)
Support Healthy Cholesterol Levels with HCP’s New LipiCept™ with Pantesin® Pantethine

Lowering LDL cholesterol levels is clinically proven to help reduce cardiovascular risks. But reducing “bad" cholesterol is the first step; levels need to stay in healthy ranges for the greatest benefits.

That's where LipiCept™ Cholesterol Support from HCP Formulas can make a difference. Two capsules taken twice daily provides a powerful blend of Pantesin® Pantethine-a branded form of a Vitamin B5 derivative-and Sytrinol® citrus and palm extracts. Pantesin® has been shown to lower LDL and non-HDL (good) cholesterol levels while increasing valuable CoQ10 stores.*

A study published in Vascular Health and Risk Management showed Pantesin® participants saw an 11% decrease in LDL cholesterol levels compared to 3% of those taking placeboes.* For more information about the study, visit

LipiCept™ also contains 0.65 grams of plant sterols per serving. Foods containing at least 0.65 grams per serving of plant sterol esters, eaten twice a day with meals for a daily total intake of at least 1.3 grams, as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. Plant sterol esters have been shown to lower blood cholesterol.*

For more information, visit

About HCP Formulas
HCP Formulas specializes in ultra-premium nutraceutical remedies. Our world-class enzymes are formulated for maximum effectiveness by leading enzymologists, scientists, and health professionals. We source only the highest-grade ingredients and utilize cutting-edge delivery systems. We manufacture in the USA in GMP registered facilities. For more information, visit

About Pantesin® Pantethine
Pantesin® is a high-quality, pharmaceutical grade branded form of Pantethine, a derivative of vitamin B-5. Supplied worldwide by Kyowa Pharma Chemical Co., a subsidiary of Kyowa Hakko Bio Co. Ltd. (Kyowa Hakko Bio), and distributed by Kyowa Hakko U.S.A., the ingredient Pantesin® can be found in many dietary supplements designed to support heart health. Pantesin® has been well-researched for over 35 years, including human clinical studies in both Asian and North American countries, and has been shown to provide vital cardiovascular health benefits. For more information on Pantesin®, visit

Pantesin® is a registered trademark of Kyowa Pharma Chemical Co.

About Kyowa Hakko USA
Kyowa Hakko USA is the North & South American office for Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing, and marketing of pharmaceuticals, nutraceuticals and food products. Kyowa is the maker of branded ingredients including Cognizin® Citicoline, Pantesin® Pantethine, Setria® Glutathione, as well as Sustamine® L-Alanyl-L-Glutamine. For more information visit

Sytrinol® branded blend of citrus and palm fruit extracts. (U.S. Patents 6987125 and 7683095) Sytrinol® is a registered trademark of InterHealth N.I.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

# # #

Read the full story at

Page: 1

Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Bellevue Asset Management AG: Bellevue launches dedicated digital health fund
  • Global Chromatography Reagents Market Analysis, Growth, Trends & Forecast 2018-2023, With The Market Forecasted to Register a CAGR of More Than 7% -
  • Life Science Reagents Market to exceed US$ 67.0 Bn by 2026, Says TMR
  • Study on Poor Oral Hygiene Habits of Aging Population Underlines the Importance of Outstanding Dental Care, says Premier Care Dental Group
  • Blood Gas and Electrolyte Analyzer Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2023

  • Lion TCR receives US$ 20 million to fund its personalized T cell therapy clinical trials against Liver cancer
  • NASP Applauds Bipartisan Legislation Introduced to Reduce Drug Costs and Support Access for Seniors with Life-Threatening Specialized Conditions
  • Celgene Corporation Announces Additional $3 Billion Share Repurchase Authorization and Plans to Execute a $2 Billion Accelerated Share Repurchase Program
  • Bavarian Nordic Announces Interim Results for the First Three Months of 2018
  • Moorestown Visiting Nurse Association joins the growing enTouch network in New Jersey

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines